IP Library Granted Patent US 11,759,639
Granted Patent B2
US 11,759,639 · App. 17/361,774 · Granted Sep 19, 2023

Methods and apparatus to stimulate the heart

Inventors: Howard Levin (Teaneck, NJ); Mark Gelfand (New York, NY)
Assignee: BackBeat Medical, LLC
A61N1/36117A61N1/368A61N1/3621A61N1/3627A61N1/3684A61N1/36542A61N1/36564
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,759,639
App. No.
17/361,774
Granted
Sep 19, 2023
Kind
B2
Abstract

A method and apparatus for treatment of hypertension and heart failure by increasing secretion of endogenous atrial hormones by pacing of the heart. Pacing is done during the ventricular refractory period resulting in premature atrial contraction that does not result in ventricular contraction. Pacing results in the atrial wall stress, peripheral vasodilation, ANP secretion. Concomitant reduction of the heart rate is monitored and controlled as needed with backup pacing.

Claims (21)

1. A device for controlling heart contraction to reduce blood pressure, the device comprising:

at least one electrically conductive lead configured to connect to a heart of a patient;

an electrical pulse generator connectable to the at least one electrically conductive lead and configured to:

apply to an atrium of the heart a first atrial pacing upon expiration of a predetermined delay following an atrial refractory period of the heart and during a ventricular refractory period of the heart,

monitor a heart rate of the patient in conjunction with applying the first atrial pacing, and

apply a second atrial pacing to the atrium if the monitored heart rate is less than a predetermined minimum heart rate.

2. The device of claim 1 , wherein the electrical pulse generator is configured to reduce the predetermined delay in response to a detection of propagation of the first atrial pacing to a ventricle of the heart.

3. The device of claim 1 , wherein the electrical pulse generator is configured to periodically increase the predetermined delay to coincide with an expiration of the ventricular refractory period.

4. The device of claim 3 , wherein the electrical pulse generator is configured to set a time of the second atrial pacing to a time less than the expiration of the ventricular refractory period.

5. The device of claim 1 , wherein the electric pulse generator is configured to suspend application of the first atrial pacing and the second atrial pacing in response to a detected activity level of the patient that is above a predetermined threshold level.

6. The device of claim 5 , further comprising an activity sensor configured to detect the activity level of the patient.

7. The device of claim 1 , wherein the electrical pulse generator is configured to apply the first atrial pacing in response to a sensed ventricular depolarization of the heart.

8. The device of claim 7 , further comprising a sensor configured to sense the ventricular depolarization of the heart.

9. The device of claim 1 , wherein the electrical pulse generator is configured to apply the first atrial pacing upon expiration of a predetermined delay from a sensed ventricular depolarization of the heart.

10. The device of claim 9 , further comprising a sensor configured to sense the ventricular depolarization of the heart.

11. The device of claim 1 , wherein the electrical pulse generator is configured to apply the first atrial pacing based on a sensed atrial depolarization of the heart.

12. The device of claim 11 , further comprising a sensor configured to sense the atrial depolarization of the heart.

13. The device of claim 1 , wherein the electrical pulse generator is configured to apply the first atrial pacing between approximately 150 milliseconds and 300 milliseconds after a sensed first ventricular contraction.

14. The device of claim 13 , further comprising a sensor configured to sense the first ventricular contraction of a ventricle of the heart.

15. The device of claim 1 , wherein the atrium comprises one of a left atrium or a right atrium.

16. The device of claim 1 , wherein the predetermined minimum heart rate is less than approximately 50 beats per minute.

Assignments (8)
SECURITY INTEREST Recorded Aug 7, 2025
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; BACKBEAT MEDICAL, LLC; CALIBER THERAPEUTICS, LLC
To: MEDTRONIC, INC.
Reel/Frame 072341/0075 →
SECURITY INTEREST Recorded Aug 4, 2025
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; BACKBEAT MEDICAL, LLC; CALIBER THERAPEUTICS, LLC
To: LIGAND PHARMACEUTICALS, INC.
Reel/Frame 072359/0219 →
SECURITY INTEREST Recorded Nov 6, 2024
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC
To: HERCULES CAPITAL, INC.
Reel/Frame 069312/0758 →
RELEASE OF IP SECURITY INTEREST Recorded Oct 9, 2023
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC; ACCELERATED TECHNOLOGIES, INC.
Reel/Frame 065192/0001 →
SECURITY AGREEMENT Recorded Jun 6, 2022
From: ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC; ACCELERATED TECHNOLOGIES, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
Reel/Frame 060286/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2021
From: LEVIN, HOWARD; GELFAND, MARK
To: G & L CONSULTING, LLC
Reel/Frame 056704/0372 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2021
From: G & L CONSULTING, LLC
To: BACKBEAT MEDICAL, INC.
Reel/Frame 056704/0792 →
ENTITY CONVERSION Recorded Jun 29, 2021
From: BACKBEAT MEDICAL, INC.
To: BACKBEAT MEDICAL, LLC
Reel/Frame 056713/0454 →
Continuity (7)
Continuation 16359218 · Mar 20, 2019
Continuation 15628870 · Jun 21, 2017
Continuation 15163078 · May 24, 2016
Continuation 13688978 · Nov 29, 2012
Continuation 12555389 · Sep 8, 2009
Provisional Application 61095120 · Sep 8, 2008
Related Publication 20220008725A1 · Jan 13, 2022
Cited By (6)
US 12,208,271 US 12,239,839 US 12,246,180 US 12,440,653 US 12,458,805 US 12,605,554